HighTower Advisors
ZOM

HighTower Advisors’s Zomedica Corp. ZOM Stock Holding History

HighTower Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,525
Closed -$7.86K – 4117
2024
Q4 		$7.86K Buy
65,525
+200
+0.3% +$25 ﹤0.01% 3597
2024
Q3 		$9K Hold
65,325
– – ﹤0.01% 3560
2024
Q2 		$10K Hold
65,325
– – ﹤0.01% 3452
2024
Q1 		$9K Buy
+65,325
New +$9.14K ﹤0.01% 3409
2020
Q3 		– Sell
-14,000
Closed -$3K – 2754
2020
Q2 		$3K Buy
+14,000
New +$2.67K ﹤0.01% 2374

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

HighTower Advisors's ZOM Position: Q1 2025 in Review

HighTower Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 65,525 shares — an estimated $7.86K sold.

HighTower Advisors first reported a position in ZOM in Q2 2020 and held it in 5 quarters. The position peaked at $10K in Q2 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • HighTower Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 65,525 Zomedica Corp. shares in Q1 2025, an estimated $7.86K.
  • HighTower Advisors first reported a position in Zomedica Corp. in Q2 2020 and held it in 5 quarters.
  • HighTower Advisors's Zomedica Corp. position peaked at $10K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.